Coherus Oncology: Peers

The FY2023 (Dec) proxy of Coherus Oncology names 21 peer companies for pay. Among Coherus Oncology and these peers, CEO pay was 5th highest of 8 and total shareholder return was the lowest of 8.

5th highest of 8in Coherus Oncology and its pay peers, FY2023 (Dec) by CEO pay:

$3.1M$8.9M

8th highest of 8in Coherus Oncology and its pay peers, FY2023 (Dec) by total shareholder return:

-$82$185

Pay peer group, FY2023 (Dec) proxy

PTC Therapeutics
Ironwood Pharmaceuticals
Pacira BioSciences
Mirum Pharmaceuticals
Agenus
Agios Pharmaceuticals
Nektar Therapeutics
Acadia PharmaceuticalsNot disclosedNot disclosed
Aerie PharmaceuticalsNot disclosedNot disclosed
Amicus PharmaceuticalsNot disclosedNot disclosed
Collegium PharmaceuticalsNot disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Deciphera PharmaceuticalsNot disclosedNot disclosed
Dynavax TechnologiesNot disclosedNot disclosed
Eagle PharmaceuticalsNot disclosedNot disclosed
FibrogenNot disclosedNot disclosed
Heron TherapeuticsNot disclosedNot disclosed
Intercept PharmaceuticalsNot disclosedNot disclosed
Karyopharm TherapeuticsNot disclosedNot disclosed
Supemus PharmaceuticalsNot disclosedNot disclosed
Vanda PharmaceuticalsNot disclosedNot disclosed
21 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.